Mycophenolate Mofetil Capsule
Product Images NDC 72888-192

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 72888-192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (1185ccbb 0558 4380 91b7 38402b9fefab 01)

FDA Label Image

Image (1185ccbb 0558 4380 91b7 38402b9fefab 02)

FDA Label Image

Mmt (1185ccbb 0558 4380 91b7 38402b9fefab 03)

Mmt (1185ccbb 0558 4380 91b7 38402b9fefab 03)
This text appears to be the description and important information for a medication called Mycophenolate Mofetil. Each film-coated tablet contains 500 mg of Mycophenolate Mofetil USP. The usual dosage and other prescribing information can be found in the accompanying insert. The tablets should be stored in a tight, light-resistant container with a child-resistant cap, at a temperature between 25°C (77°F) and 30°C (86°F). Special handling and disposal instructions should be followed as indicated in the insert. The medication should be kept out of reach of children. The manufacturing company is Concord Biotech Limited, located in Valthera, Ahmedabad, Gujarat, India. The medication is available in a pack of 500 tablets. Pharmacists are instructed to dispense the accompanying medication guide to each patient. Further information can be found at the website provided or by scanning the given QR code. The medication is manufactured for Advagen Pharma Limited, located in Plainsboro, NJ, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.